AbbVie sees promising early-stage data for weight loss asset ABBV-295
Source: SeekingAlpha
2026-03-09 09:26:27 ET
Read the full article on Seeking Alpha
For further details see:
AbbVie sees promising early-stage data for weight loss asset ABBV-295
AbbVie Inc.
NASDAQ: ABBV
ABBV Trading
0.28% G/L:
$227.75 Last:
2,502,159 Volume:
$227.66 Open:
ABBV Latest News
ABBV Stock Data
$396,361,630,803
1,749,710,786
N/A
2503
N/A
Pharmaceuticals
Healthcare
US
North Chicago
